The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations

Jing-Hui Lin; Dong Lin; Ling Xu; Qiang Wang; Hui-Hua Hu; Hai-Peng Xu; Zhi-Yong He

doi:10.18632/oncotarget.13787

The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations

Oncotarget ◽

10.18632/oncotarget.13787 ◽

2016 ◽

Vol 8 (2) ◽

pp. 3412-3421 ◽

Cited By ~ 5

Author(s):

Jing-Hui Lin ◽

Dong Lin ◽

Ling Xu ◽

Qiang Wang ◽

Hui-Hua Hu ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Retrospective Assessment ◽

Epidermal Growth ◽

Egfr Tki

Download Full-text

Combination effects of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) and individual chemotherapeutics in non-small cell lung cancer (NSCLC) cells with and without sensitizing-EGFR mutations.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e18062 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e18062-e18062

Author(s):

C. Tsai ◽

K. Chang ◽

C. Chiu ◽

S. Hsiao

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tki

Download Full-text

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2019.05.032 ◽

2019 ◽

Vol 117 ◽

pp. 107-115 ◽

Cited By ~ 7

Author(s):

Zong-Han Yao ◽

Wei-Yu Liao ◽

Chao-Chi Ho ◽

Kuan-Yu Chen ◽

Jin-Yuan Shih ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor, in Patients with Platinum Refractory Non-small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000263712.61697.69 ◽

2007 ◽

Vol 2 (4) ◽

pp. 299-305 ◽

Cited By ~ 44

Author(s):

Shirish M. Gadgeel ◽

John C. Ruckdeschel ◽

Elisabeth I. Heath ◽

Lance K. Heilbrun ◽

Raghu Venkatramanamoorthy ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Platinum Refractory ◽

Epidermal Growth ◽

Cox 2 ◽

Egfr Tki

Download Full-text

The plasma ctDNA monitoring during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial)

Annals of Oncology ◽

10.1093/annonc/mdy292.046 ◽

2018 ◽

Vol 29 ◽

pp. viii514

Author(s):

K. Usui ◽

T. Yokoyama ◽

A. Kisohara ◽

Y. Mori ◽

Y. Takeda ◽

...

Keyword(s):

Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Tki Treatment ◽

Egfr Mutant ◽

Egfr Tki

Download Full-text

125P Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor

Annals of Oncology ◽

10.1016/j.annonc.2020.08.246 ◽

2020 ◽

Vol 31 ◽

pp. S290

Author(s):

Y-J. Zhu ◽

H-B. Zhang ◽

X-S. Chang ◽

Z-Z. Xiao ◽

L-R. Liu ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Dacomitinib, a second-generation irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) to treat non-small cell lung cancer

Drugs of Today ◽

10.1358/dot.2019.55.4.2965337 ◽

2019 ◽

Vol 55 (4) ◽

pp. 231 ◽

Cited By ~ 4

Author(s):

T. Nagano ◽

M. Tachihara ◽

Y. Nishimura

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tki

Download Full-text

Antitumor activity of the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 (‘lressa’), alone or combined with gemcitabine and vinorelbine platinum-based chemotherapy, in human non-small-cell lung cancer (NSCLC) xenografts

European Journal of Cancer ◽

10.1016/s0959-8049(02)80848-6 ◽

2002 ◽

Vol 38 ◽

pp. S62

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

Epidermal Growth ◽

Egfr Tki

Download Full-text

Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Journal of Korean Medical Science ◽

10.3346/jkms.2013.28.7.1005 ◽

2013 ◽

Vol 28 (7) ◽

pp. 1005 ◽

Cited By ~ 10

Author(s):

Jae-Heon Jeong ◽

Byoung Chul Cho ◽

Hyo Sup Shim ◽

Hye-Ryun Kim ◽

Sun-Min Lim ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Progression Free Survival ◽

Transglutaminase 2 ◽

Small Cell ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation

Lung Cancer ◽

10.1016/j.lungcan.2018.12.007 ◽

2019 ◽

Vol 128 ◽

pp. 6-12 ◽

Cited By ~ 5

Author(s):

Xiangtao Yan ◽

Huijuan Wang ◽

Peng Li ◽

Guowei Zhang ◽

Mina Zhang ◽

...

Keyword(s):

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Epidermal Growth ◽

Egfr Tki ◽

First Line Treatment

Download Full-text

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review

BMC Cancer ◽

10.1186/s12885-019-5309-x ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 6

Author(s):

Takuma Imakita ◽

Hirotaka Matsumoto ◽

Katsuya Hirano ◽

Toshiyuki Morisawa ◽

Azusa Sakurai ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text